BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 11, 2013
Distillery Therapeutics

Indication: Cancer

BioCentury | Apr 11, 2013
Cover Story

RET, set, go

BioCentury | Aug 6, 2012
Clinical News

Cabozantinib: Phase II started

BioCentury | Mar 1, 2012
Cover Story

REThinking lung cancer

BioCentury | Feb 23, 2012
Distillery Therapeutics

Indication: Cancer

Items per page:
1 - 5 of 5